First line chemotherapy plus trastuzumab in metastatic breast cancer HER2 positive - Observational institutional study.

Autor:	Aitelhaj, Meryem1, Lkhoyaali, Siham1, Rais, Ghizlane1, Boutayeb, Saber1, Errihani, Hassan1
Zdroj:	Pan African Medical Journal. 2016, Vol. 24, p1-6. 6p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu